ACT 178882

Modify Date: 2025-09-22 09:10:55

ACT 178882 Structure
ACT 178882 structure
Common Name ACT 178882
CAS Number 1007392-69-9 Molecular Weight 647.031
Density 1.3±0.1 g/cm3 Boiling Point 764.3±60.0 °C at 760 mmHg
Molecular Formula C33H38Cl3N3O4 Melting Point N/A
MSDS N/A Flash Point 416.0±32.9 °C

 Use of ACT 178882


ACT 178882 is a new Renin inhibitor with an IC50 of 1.4 nM.

 Names

Name ACT 178882
Synonym More Synonyms

 ACT 178882 Biological Activity

Description ACT 178882 is a new Renin inhibitor with an IC50 of 1.4 nM.
Related Catalog
Target

IC50: 1.4 nM (Renin)[1]

In Vitro The median time to Cmax (tmax) for ACT 178882 is prolonged from 3.5 to 5.0 h by diltiazem whereas its apparent terminal half-life (t½) is unaffected by diltiazem, 22.9 and 24.2 h for treatments A and B, respectively. Using treatment A as reference, the geometric mean ratio (90% CI) is 1.62 (1.36 to 1.94) for Cmax and 2.02 (1.75 to 2.34) for AUC∞, indicating a significant interaction between ACT 178882 and diltiazem[2].
Cell Assay Venous blood samples for the determination of ACT 178882 are drawn at the following time points: pre-dose and 1, 2, 3, 4, 5, 6, 8, 12, 16, 24, 36, 48, 72, 96 and 120 h after dosing with ACT 178882 in treatment A and pre-dose and 1, 2, 3, 4, 5, 6, 8, 12, 16, 24, 36, 48, 72, 96, 120, 144, 168, 192, 216 and 240 h after dosing with ACT178882 in treatment B. For diltiazem as soon as possible after collection, and for ACT-178882 within maximally 30 minutes after collection, the tubes are centrifuged and the plasma separated. All samples are stored in an upright position at -20 °C (ACT 178882) or -80 °C (diltiazem) or below pending analysis[2].
References

[1]. Corminboeuf O, et al. Piperidine-based renin inhibitors: upper chain optimization. Bioorg Med Chem Lett. 2010 Nov 1;20(21):6291-6.

[2]. Dingemanse J, et al. Drug-drug interaction study of ACT-178882, a new renin inhibitor, and diltiazem in healthy subjects. Clin Drug Investig. 2013 Mar;33(3):207-13.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 764.3±60.0 °C at 760 mmHg
Molecular Formula C33H38Cl3N3O4
Molecular Weight 647.031
Flash Point 416.0±32.9 °C
Exact Mass 645.192810
LogP 6.12
Vapour Pressure 0.0±2.6 mmHg at 25°C
Index of Refraction 1.623
InChIKey PGSRKJVMAOWDEC-SXOMAYOGSA-N
SMILES COCCc1ccc(Cl)c(CN(C(=O)C2CNCCC2c2ccc(OCCOc3c(Cl)cc(C)cc3Cl)nc2)C2CC2)c1

 ACT 178882Bioassay

View more

Name: Inhibition of renin in buffer
Source: ChEMBL
Target: Renin
External Id: CHEMBL1275165
Name: Inhibition of renin in plasma
Source: ChEMBL
Target: Renin
External Id: CHEMBL1275166
Name: Ratio of IC50 for renin in buffer to IC50 for renin in plasma
Source: ChEMBL
Target: Renin
External Id: CHEMBL1275167
Name: Inhibition of CYP3A4 using midazolam as substrate
Source: ChEMBL
Target: Cytochrome P450 3A4
External Id: CHEMBL1275168
Name: Inhibition of CYP3A4 using testosterone as substrate
Source: ChEMBL
Target: Cytochrome P450 3A4
External Id: CHEMBL1275169
Name: Ratio of IC50 for CYP3A4 at to IC50 for CYP3A4 after 30 mins preincubation in presenc...
Source: ChEMBL
Target: Cytochrome P450 3A4
External Id: CHEMBL1275170
Name: Induction of maximal mean arterial pressure in transgenic rat harboring human angiote...
Source: ChEMBL
Target: Rattus norvegicus
External Id: CHEMBL1275171
Name: Induction of area between the curves in transgenic rat harboring human angiotensinoge...
Source: ChEMBL
Target: Rattus norvegicus
External Id: CHEMBL1275172
Name: Half life in transgenic rat harboring human angiotensinogen and human renin gene at 3...
Source: ChEMBL
Target: Rattus norvegicus
External Id: CHEMBL1275173
Name: Clearance in transgenic rat harboring human angiotensinogen and human renin gene at 3...
Source: ChEMBL
Target: Rattus norvegicus
External Id: CHEMBL1275174
Total 11, Current Page 1 of 2
1
2

 Synonyms

(3R,4S)-N-[2-Chloro-5-(2-methoxyethyl)benzyl]-N-cyclopropyl-4-{6-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]-3-pyridinyl}-3-piperidinecarboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.